与「specialty」相关的搜索结果

A director who doesn't come up to the builder's heels makes a four-hour film about him. Yesterday in Venice, Alex Gibney's nearly four-hour documentary "Musk" had its world premiere. It is a classic case of someone who has spent a career telling other people's stories taking on a man who actually builds those stories with rockets, cars, satellites, and infrastructure, not slides. Alex Gibney is an acclaimed documentarian. An Oscar for Taxi to the Dark Side, Emmys for Going Clear on Scientology, high-profile films on Enron, Elizabeth Holmes and Theranos. His specialty is exposing corporations, cults, and frauds. He does it skillfully and with a thesis. The problem starts when he applies the same method to someone who is not selling an illusion, but hardware that either flies or blows up in front of the entire world. Gibney's fuel is controversy. Elon's fuel is the pursuit of truth hard, engineering truth, the kind that either works on the test stand or it doesn't. It would have been enough to make a film based on facts. Instead we got another rut that fits the slogans of provocation: megalomaniac, confidence man, threat to democracy, an AI avatar reciting old quotes, ex-wives, his father, a former partner. Musk said in 2023 it would be a hit piece. After the premiere, a large share of reviewers effectively agreed with him. I don't know about you, but four hours of falsified formulas would bore me. Instead I watch how much Elon has already done. His energy is extraordinary. Tesla changed the car industry. SpaceX brings rockets back. Starlink works. Starship stands on the pad and prepares for the next flight. This is not a PowerPoint. It is steel, fuel, engines, and people who cannot hide failure in the edit suite. A weak documentary like this is a crumb on the shoulder of his jacket. Now it depends on us when and how quickly that blown-off crumb a utopian attention vampire is simply starved of attention. You could list the names of people who tried to take Elon's energy. Energy is the most precious thing we have. Anyone who steals it with slogans, gossip, and a four-hour indictment that excludes the main subject is sowing under his own feet. Gibney: you reap what you sow. If you have a shred of shame, look at the list of Elon's accomplishments. Look at what kind of person he is for the world and what he does around himself so that things get better cars that drive, internet from orbit, rockets that return, attempts at a brain-computer interface, AI that is supposed to be more than another chatbot. You can dislike his tweets, his political alliances. You cannot honestly erase the scale of what was physically built. A good documentarian should stand, at least for a moment, in the shoes of the person he is portraying. Gibney did not just fail to do that. He took a measure cut for Enron and Holmes and held it up to a man who lands rockets. He left Elon's shoes in the edit suite. Elon walked on barefoot and kept building. One man tells stories about the world from an editing chair. The other moves that world. A four-hour film will not change that. At most it will confirm what people who already disliked Musk already believed. Everyone else can blow the crumb off the jacket and keep going. History does not judge a man by the length of a film. It judges him by what is still in the air when the camera has stopped running. Controversy feeds on attention. Building feeds on repetition. One vanishes when you look away. The other keeps flying. You can cut a man together in four hours. You cannot cut a landing together. A documentary can be switched off. The work cannot.

Precipio, Inc. (@PrecipioDx ) (@Nasdaq : $PRPO ) reported revenue of $7.0 million for the second quarter ended June 30, 2026, the highest quarterly revenue in the company’s history and an increase of 22% from $5.7 million in the second quarter of 2025. The specialty cancer diagnostics company validates its technologies clinically in its own laboratory before commercializing them for the global laboratory community. Precipio, Inc. is a B2i Digital (@b2idigital )Featured Company. See the company’s in-depth profile at: Both sides of the business contributed, with pathology services and diagnostic products each growing sequentially: • Revenue surpassed $7 million for the first time in company history, rising from $6.7 million in the first quarter • Product revenue reached $0.9 million, an increase of 21% over the previous high of $750,000 in the fourth quarter of 2025, and pathology revenue reached $6.1 million • Adjusted EBITDA, a non-GAAP measure the company reconciles in the release, was positive at $0.4 million for the quarter • Cash flow from operations was $0.7 million, and cash ended the quarter above $3 million against $1.1 million a year earlier • Management will discuss the quarter on a shareholder call on August 17, 2026 at 5 p.m. ET, followed by a moderated question and answer session The conference call may be accessed by calling 646.307.1865. All callers should ask for the Precipio Inc. conference call. Regarding the cash balance, Ilan Danieli, Chief Executive Officer of Precipio, stated: “We’ve achieved this level of cash without a financing event, demonstrating the strength of our operations. We’re encouraged by the progress we’ve made and believe we are well positioned to continue building on this momentum.” Read the full release: Precipio is a healthcare biotechnology company focused on cancer diagnostics. Its mission is to address the pervasive problem of cancer misdiagnoses by developing solutions in the form of diagnostic products and services that deliver higher accuracy, improved laboratory workflow, and better patient outcomes, which reduce healthcare expenses. Precipio develops innovative technologies in its laboratory where it designs, tests, validates, and uses these products clinically, then commercializes them as proprietary products that serve the global laboratory community. More information is available at Discover more emerging growth Featured Companies, Featured Experts, and upcoming Featured Conferences at B2i Digital is not a broker-dealer or investment adviser. This post is informational and not an offer or solicitation regarding any security. See the complete Disclosure at

𝗧𝗛𝗜𝗦 𝗜𝗦 𝗠𝗨𝗖𝗛 𝗕𝗜𝗚𝗚𝗘𝗥 𝗧𝗛𝗔𝗡 “𝗧𝗛𝗘 𝗣𝗘𝗡𝗧𝗔𝗚𝗢𝗡 𝗠𝗔𝗬 𝗨𝗦𝗘 𝗔𝗜.” President Donald Trump’s new Executive Order signals a fundamental change in defense acquisition: contractors will increasingly be expected to prove where critical materials, components, equipment, and software originate—through subcontractors and toward the raw-material source. The Pentagon wants to see the defense supply chain, identify where an adversary could interrupt it, and make prohibited foreign sourcing harder to excuse. The order directs the Department of Defense to: • Map designated critical supply chains. • Obtain hierarchical bills of materials showing what is inside a defense product, who supplied it, and where it originated. • Extend visibility beyond prime contractors into lower-tier suppliers. • Identify foreign dependencies, bottlenecks, sole-source suppliers, concentration risks, and single points of failure. • Use AI to analyze acquisition data and expose connections conventional contract reviews may miss. • Accelerate qualification of alternative sources and materials. Beginning January 1, 2027, certain waivers involving covered materials from prohibited sources will become substantially harder to obtain. Contractors seeking waivers may need approved mitigation plans showing how the dependency will be reduced or removed. Fraud, deliberate misrepresentation, or willful failure to implement an approved plan could result in contractual remedies and possible referral to the Attorney General. Restrictions under 10 U.S.C. §4872 concern designated sensitive materials from China, Russia, North Korea, and Iran, including certain specialty metals, rare-earth elements, permanent magnets, and tungsten-related materials. But one distinction matters: 𝗔𝗜 𝗜𝗦 𝗡𝗢𝗧 𝗕𝗘𝗜𝗡𝗚 𝗔𝗨𝗧𝗛𝗢𝗥𝗜𝗭𝗘𝗗 𝗧𝗢 𝗗𝗘𝗖𝗜𝗗𝗘 𝗜𝗡𝗗𝗘𝗣𝗘𝗡𝗗𝗘𝗡𝗧𝗟𝗬 𝗪𝗛𝗜𝗖𝗛 𝗖𝗢𝗠𝗣𝗔𝗡𝗜𝗘𝗦 𝗔𝗥𝗘 𝗧𝗥𝗨𝗦𝗧𝗪𝗢𝗥𝗧𝗛𝗬. AI will help map and analyze supply-chain vulnerabilities. Human officials retain responsibility for waivers, mitigation plans, contracting actions, and enforcement. President Trump and Secretary of Defense Pete Hegseth deserve recognition for this determination to expose hidden dependencies and strengthen the industrial foundation behind the American warfighter. Now comes the decisive test: implementation. AI cannot map what contractors cannot identify, subcontractors will not disclose, or suppliers report inaccurately. 𝗦𝗨𝗣𝗣𝗟𝗬-𝗖𝗛𝗔𝗜𝗡 𝗠𝗔𝗣𝗣𝗜𝗡𝗚 𝗜𝗦 𝗡𝗢𝗧 𝗔𝗗𝗠𝗜𝗡𝗜𝗦𝗧𝗥𝗔𝗧𝗜𝗩𝗘 𝗖𝗢𝗠𝗣𝗟𝗜𝗔𝗡𝗖𝗘. 𝗜𝗧 𝗜𝗦 𝗔 𝗧𝗘𝗦𝗧 𝗢𝗙 𝗪𝗛𝗘𝗧𝗛𝗘𝗥 𝗧𝗛𝗘 𝗦𝗬𝗦𝗧𝗘𝗠 𝗕𝗘𝗛𝗜𝗡𝗗 𝗧𝗛𝗘 𝗪𝗔𝗥𝗙𝗜𝗚𝗛𝗧𝗘𝗥 𝗖𝗔𝗡 𝗦𝗨𝗥𝗩𝗜𝗩𝗘 𝗖𝗢𝗡𝗧𝗔𝗖𝗧 𝗪𝗜𝗧𝗛 𝗪𝗔𝗥. “Don’t sell me hype and call it readiness. Prove it before you put a soldier’s life behind it.” — Linda Restrepo Editor-in-Chief, N360™ — Sovereign Intelligence & National Security Technologies #DefenseSupplyChain# #ArtificialIntelligence# #DefenseIndustrialBase# #NationalSecurity# #MilitaryReadiness#

📍Nanchang, Jiangxi丨A Brazilian Tries Nanchang Shuizhu for the First Time 🌶️ Bursting with bold spices, fresh ingredients, and irresistible aroma, this local specialty delivers an unforgettable flavor experience. 😋 Every mouthful is packed with the signature heat and rich taste that make Shuizhu a favorite among locals. @EmbaixadaChina @XinhuaTravel @XHNews @TripInChina @AmbXieFeng #Jiangxi# #ChineseFood# #JiangxiFriends# #ChinaTravel# #reels#

#DYK# that the #FBI#'s specialty teams work behind the scenes to secure special events? Follow @FBI to learn more about the work our Critical Incident Response Group has done to make sure Americans, and our foreign visitors safely enjoy the #FIFAWorldCup2026#.

𝟮𝗻𝗱 𝗣𝗟𝗔𝗬𝗘𝗥 : 𝗣𝗢𝗥 Specialty : Radiant Aura Skin Power : 100% Ultimate Glow Boost Let's set new skin rules and shine bright like a winner with him.

🤝During the 32nd China Lanzhou Investment and Trade Fair, South Korea, one of the guest countries of honor, deepened exchanges with Gansu. Both sides are exploring win-win cooperation in NEVs, biomedicine, advanced manufacturing and specialty agriculture, building on the Silk Road spirit for a brighter future.

Kiwi Pick: 🇵🇹Portugal 2:1 Croatia 🇭🇷 (Portugal wins after extra time) The last dance of two former Real Madrid CF legends — 41-year-old Cristiano Ronaldo and 40-year-old Luka Modrić. Neither side has looked fully convincing on the way here. Portugal smashed Uzbekistan 5-0, but their other performances were mostly flat and uninspiring. Croatia barely scraped past Ghana through pure grit. Portugal have the deeper squad and a more solid defense, conceding almost nothing in the group stage. But Croatia’s specialty is dragging stronger teams into those painful, exhausting final moments where everything gets messy.

Today, China’s reported pause on new cross-border TRS allocations. This could have a larger impact on global semiconductor equities than many realize. Chinese HFs have evolved into some of the most sophisticated researchers of the semiconductor supply chain globally. They are often early in identifying underfollowed opportunities long before they become consensus trades. In recent years, they were among the early buyers of photonics names such as LITE and storage-related names such as SNDK before broader institutional participation arrived. Their reach extends well beyond the US into Korea, Taiwan and Japan, particularly across MLCC, power semis, analog, specialty materials, equipment and component suppliers. If cross-border TRS growth is restricted, many small/mid-cap semiconductor names could lose an important source of marginal demand and price discovery. Negative for breadth across KR/TW/JP semis. Potentially positive for HK-listed semiconductor as capital is redirected toward markets with fewer outbound constraints.

📊 @Solana is the largest network by RWA holder count at 290,353, up 133.5% year-to-date Below is the breakdown by asset class and market share: 1) Stocks: 234.6K (80.8%) 2) Commodities: 27.2K (9.4%) 3) U.S. Treasury Debt: 8.9K (3.1%) 4) Specialty Finance: 8.1K (2.8%) 5) Asset-Backed Credit: 5.6K (1.9%) 6) Non-US Government Debt: 4.3K (1.5%) 7) Real Estate: 1.3K (0.5%) 8) Diversified Credit: 159 (0.1%) 9) Corporate Credit: 71 (0.02%) 10) Active Strategies: 27 (0.01%) 11) Private Equity: 20 (0.01%) 12) Cryptocurrencies: 12 (0.01%)